Alex Biese

One expert explained why ‘it’s very important to know what’s going on’ with regard to new renal cell carcinoma treatments.

Researchers have identified genetic differences that can make leukemia relapse more or less likely among pediatric patients.

Researchers compared health-related quality of life among patients ages 60 and older with acute myeloid leukemia undergoing different chemotherapy regimens.

With attitudes evolving around telemedicine in oncology, one doctor explains how patients can get ready for a video appointment with their provider.

One researcher explains the science behind Lymphir, recently approved by the FDA for relapsed/refractory cutaneous T-cell lymphoma.

One expert explains how a break in TKI treatment could alleviate some toxicities, such as rash, for patients with non-small cell lung cancer.

The cancer vaccine, mRNA-4157, garnered immune responses of 30 weeks among some patients with melanoma and lung cancer, study results showed.

The FDA has approved Voranigo to treat certain patients with grade 2 astrocytoma or oligodendroglioma with select mutations, following surgery.

Revised guidelines also recommend mindfulness-based programs, yoga, acupressure and more to ease cancer-related fatigue.

CURE® spoke to an expert from Emory University in Atlanta about tonsil cancer, its “gold standard” treatment and potential side effects.

The Food and Drug Administration approved Jemperli with carboplatin and paclitaxel for primary advanced or recurrent endometrial cancer.

23andMe and 20 lung cancer advocacy organizations are working to improve lung cancer detection, risk reduction and care.

“Patients did great” with a four-drug regimen for multiple myeloma, an expert told CURE®.

From radiopharmaceuticals to hypofractionated radiation therapy, one expert explained the current landscape of radiation treatments for prostate cancer.

Reduced doses of radiation were shown to be effective for some patients with indolent orbital B-cell lymphoma, researchers said.

Researchers have found that among patients with certain melanoma, presurgical targeted therapy and immunotherapy can result in better pathologic response.

Citing toxicities and lack of efficacy, some are calling for caution when treating older patients with melanoma with immune checkpoint inhibitors.

A second dendritic cell vaccine has received fast track designation from the Food and Drug Administration.

Nubeqa plus androgen deprivation therapy displayed positive radiological progression-free survival results in early trial data.

For some patients with early non-small cell lung cancer and lung scarring, stereotactic ablative radiotherapy may be a viable option, research has shown.

One expert explains what patients with prostate cancer interested in clinical trial participation need to know.

A radiation oncology nurse explains the spectrum of side effects that can come with radiation for prostate cancer.

One radiation oncologist describes the advantages of MRI-guided SBRT when treating patients with prostate cancer.

While adherence to germline testing has been found to be low, one expert explained why tests findings could matter to patients.

As part of our “Speaking Out” video series, we look at the association between prostate cancer and mental health.

Updated data has been reported evaluating efti and Keytruda in PD-L1 negative recurrent or metastatic head and neck squamous cell carcinoma.

One expert from the University of Colorado Cancer Center explains the multidisciplinary aspect of sarcoma care to maximize patients’ functioning.

Patients with favorable-risk prostate cancer “should be aware that they don't need treatment right away,” one expert said.

The TIL therapy OBX-115 ‘may have the potential to address’ an unmet need among patients with metastatic or locally advanced melanoma.

Perioperative treatment with BRAF and MEK inhibitors was found to benefit some patients with stage 3 and 4 melanoma, according to a recent study.